BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10225777)

  • 1. Therapeutic apheresis in malignancy.
    Nand S
    Ther Apher; 1997 Feb; 1(1):29-32. PubMed ID: 10225777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasmapheresis and protein A immunoadsorption in malignancy: a brief review.
    Nand S; Molokie R
    J Clin Apher; 1990; 5(4):206-12. PubMed ID: 2229001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical use of protein-A immunoadsorption].
    Aksenov VA
    Ter Arkh; 1996; 68(11):83-5. PubMed ID: 9045392
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic apheresis in myasthenia gravis patients: a six year follow-up.
    Schneidewind JM; Zettl UK; Winkler RE; Ramlow W; Tiess M; Hofmann D; Michelsen A; Weber G; Kinze EM; Adam U; Hauk L; Behnecke R; Klinkmann H
    Ther Apher; 1999 Nov; 3(4):298-302. PubMed ID: 10608721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of circulating immune complexes: their role in host-tumor interactions and removal by immunoadsorption therapy.
    Phillips TM; Holohan TV; Korac S; More NS; Queen WD
    Contemp Top Immunobiol; 1985; 15():111-37. PubMed ID: 3161698
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic apheresis in multiple sclerosis].
    Nomura K
    Nihon Rinsho; 2003 Aug; 61(8):1388-95. PubMed ID: 12962028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.
    Snyder HW; Mittelman A; Oral A; Messerschmidt GL; Henry DH; Korec S; Bertram JH; Guthrie TH; Ciavarella D; Wuest D
    Cancer; 1993 Mar; 71(5):1882-92. PubMed ID: 8448753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
    Snyder HW; Reed DE; Jones FR
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
    Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
    Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmapheresis-immunoadsorption for treatment of systemic lupus erythematosus in a dog.
    Matus RE; Scott RC; Saal S; Gordon BR; Hurvitz AI
    J Am Vet Med Assoc; 1983 Mar; 182(5):499-502. PubMed ID: 6339455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocytoclastic vasculitis following staphylococcal protein A column immunoadsorption therapy. Two cases and a review of the literature.
    Arbiser JL; Dzieczkowski JS; Harmon JV; Duncan LM
    Arch Dermatol; 1995 Jun; 131(6):707-9. PubMed ID: 7778924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.
    Deodhar A; Allen E; Daoud K; Wahba I
    Semin Arthritis Rheum; 2002 Aug; 32(1):3-9. PubMed ID: 12219317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein A immunotherapy in the treatment of cancer: an update.
    Messerschmidt GL; Henry DH; Snyder HW; Bertram J; Mittelman A; Ainsworth S; Fiore J; Viola MV; Louie J; Ambinder E
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):19-24. PubMed ID: 2658096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal toxicity during protein A immunoadsorption treatment of malignant disease: an outpatient therapy.
    Snyder HW; Henry DH; Messerschmidt GL; Mittelman A; Bertram J; Ambinder E; Kiprov D; Balint JP; MacKintosh FR; Hamburger M
    J Clin Apher; 1991; 6(1):1-10. PubMed ID: 2045375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of plasmapheresis, lymphocytapheresis, and staph protein-A immunoadsorption as an immunomodulatory therapy in patients with AIDS and AIDS-related conditions.
    Kiprov DD; Lippert R; Miller RG; Sandstrom E; Jones FR; Cohen RJ; Abrams D; Busch DF
    J Clin Apher; 1986; 3(2):133-9. PubMed ID: 2939064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking (suppressor) factors, immune complexes, and extracorporeal immunoadsorption in tumor immunity.
    Hellström KE; Hellström I; Snyder HW; Balint JP; Jones FR
    Contemp Top Immunobiol; 1985; 15():213-38. PubMed ID: 2992879
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments.
    Jones FR; Grant CK; Snyder HW
    J Biol Response Mod; 1984; 3(3):286-92. PubMed ID: 6086847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apheresis in dermatologic diseases].
    Strangi RM; D'Ascenzo G; Bilenchi R; Trovato E; Sansica P; Gorgoglione V
    G Ital Nefrol; 2012; 29 Suppl 54():S119-24. PubMed ID: 22388842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of the staphylococcal protein A immunoadsorption column.
    Morrison FS; Huestis DW
    J Clin Apher; 1992; 7(4):171-2. PubMed ID: 1299653
    [No Abstract]   [Full Text] [Related]  

  • 20. A trial of autologous plasma perfusion over protein A in patients with breast cancer.
    Fer MF; Beman J; Stevenson HC; Maluish A; Moratz C; Delawter T; Foon K; Herberman RB; Oldham RK; Terman DS
    J Biol Response Mod; 1984; 3(3):352-8. PubMed ID: 6235326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.